Page 2341 - Markets News

Glenmark Pharma zooms 28% on launch of Favipiravir, a potential Covid drug

The company launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet.

Adani Power board okays delisting from BSE, NSE; to seek shareholders' nod

The company has worked out the floor price of an equity share of Rs 33.82 to buy 96.53 crore scrips with the public for about Rs 3,264 crore

Bank of Baroda Q4 preview: Covid-19, telecom stress may keep earnings muted

Kajal Gandhi and Vishal Narnolia, research analysts at ICICI Securities, believe that Covid-19 breakout and merger process would lead to sluggish business growth during the quarter under review.

SBI Cards hits 12-week high on heavy volumes, zooms 28% in a month

SBI Cards made its stock market debut on March 16, 2020

RIL 57th most valuable firm globally by market-cap; Saudi Aramco tops chart

Following stellar gains in its share price, RIL became the first Indian firm to achieve the milestone of crossing Rs 11 trillion market valuation mark on Friday

Sebi reports 13% income growth at Rs 963 cr in 2018-19 over rise in fees

The regulator's fee income surged to Rs 750 crore from Rs 624 crore and other income rose to 17 crore from nearly Rs 10 crore

ICICI Bank, SBI: Fitch revises IDR outlook. Time to sell these stocks?

On Monday, global rating agency Fitch revised the outlook from "stable" to "negative" on the Long-Term Issuer Default Ratings (IDR) of nine Indian banks

IT stocks muted as US may announce foreign workers' visa restrictions today

"We're going to be announcing something tomorrow or the next day on the visas," Donald Trump said on Saturday.

Cipla hits 52-wk high on launch of generic remdesivir for Covid-19 patients

Remdesivir is the only USFDA approved emergency use authorization treatment in severe (hospitalised) Covid-19 patients.

RIL gains 2.5%, hits fresh record high; stock zooms over 100% in 3 months

In the past three months, the stock price of RIL has zoomed 104 per cent from its March low of Rs 883.85 hit on March 23, as compared to 35 per cent rise in the benchmark S&P BSE Sensex.

ICICI Bank gains over 3% after paring stake in ICICI Prudential Life

ICICI Pru Life's stock also rose 5.68 per cent to Rs 413.95 on the BSE after the stake sale

Stocks to watch: Glenmark, Cipla, IT stocks, HDFC, Sudarshan Chemical Ind

Here's a look at the top stocks that may remain on focus today

Nifty outlook and stock recommendations by CapitalVia: Buy RBL Bank, ONGC

As per monthly option data, a handful of put writing on higher strikes ranging from 9,900 to 10,200 is seen which shows Nifty might witness support in subzone of 10,000

Stock picks by Vaishali Parekh of Prabhudas Lilladher: Buy HDFC AMC, ABB

The stock of ABB has made a higher bottom formation pattern taking support near 776 levels and has picked up with momentum to improve the bias

Market Ahead, June 22: Top factors that could guide markets this week

The Indian markets are likely to start this week on a flat note with a negative bias, on the back of similar trend in global indices

Eight of top 10 firms add Rs 1.76 trillion in m-cap; Reliance leads rally

Top losers were ITC, HUL

I'm very bullish on EM equities for next few years, says Jan Dehn

'EMs will significantly outperform developed market (DM) assets. Both bonds and stocks, as well as currencies,' he says

Women form less than 25% of most Indian companies' board, says study

The average transparency rating for Indian companies is 34 per cent, higher than the average transparency rating of 25 per cent across the companies universe

Rate-sensitive sectors on a strong run since RBI's 40 bps repo rate cut

The move brought the repo rate to 4 per cent, which is the lowest since 2000

Street signs: Lacklustre retail demand for OFS, bond sales, and more

Retail investors - those investing up to Rs 200,000 - did not subscribe to all the shares on offer despite arbitrage gains on the table